Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials

IMPORTANCE: Flortaucipir positron emission tomography (PET) scans, rated with a novel, US Food and Drug Administration–approved, clinically applicable visual interpretation method, provide valuable information regarding near-term clinical progression of patients with Alzheimer disease (AD) or mild c...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:JAMA Neurol
Hoofdauteurs: Lu, Ming, Pontecorvo, Michael J., Devous, Michael D., Arora, Anupa K., Galante, Nicholas, McGeehan, Anne, Devadanam, Catherine, Salloway, Stephen P., Doraiswamy, P. Murali, Curtis, Craig, Truocchio, Stephen P., Flitter, Matthew, Locascio, Tricia, Devine, Marybeth, Zimmer, Jennifer A., Fleisher, Adam S., Mintun, Mark A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Medical Association 2021
Onderwerpen:
Original Investigation
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7885097/
https://ncbi.nlm.nih.gov/pubmed/33587110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2020.5505
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items